Travere Therapeutics is a San Diego biopharmaceutical company that develops and sells treatments for rare kidney and metabolic diseases. It last closed at $51.10 on Nov 17, up 2.82% on the day. TVTX last reported earnings on Mon, Nov 2, 2026. The average 12-month price target from 6 analysts is $74.33 (+45.5% from the last close), with a high of $86.00 and a low of $67.00. Analyst consensus is Strong Buy, based on the latest ratings from 6 firms (6 buy, 0 hold, 0 sell). In the past 30 days there were 3 dark pool prints totaling $5.1M, the largest $2.6M.
Each firm's latest rating on TVTX in the past 90 days
Average 12-month target
$74.33
▲ 45.5% upside
Based on 6 analysts who set a price target on TVTX in the past 90 days. The average target is $74.33, with a high of $86.00 and a low of $67.00, compared with the last close of $51.10.
Low $67.00Avg $74.33High $86.00
Blue marker: last close $51.10
Highest target$86.00
Average target$74.33
Lowest target$67.00
Latest rating changes
JP MorganMaintained
Nov 7Buy$86
Leerink PartnersMaintained
Nov 5Buy$67
Canaccord GenuityTarget raised
Nov 4Buy$70 → $72
GuggenheimTarget lowered
Nov 4Buy$89 → $78
GuggenheimTarget raised
Sep 24Buy$75 → $89
Date
Firm
Action
Rating
Price target
Nov 7
JP Morgan
Maintained
Buy
$86
Nov 5
Leerink Partners
Maintained
Buy
$67
Nov 4
Canaccord Genuity
Target raised
Buy
$70 → $72
Nov 4
Guggenheim
Target lowered
Buy
$89 → $78
Sep 24
Guggenheim
Target raised
Buy
$75 → $89
Loading…
Technical Analysis
TVTX · as of the Nov 17 close · updated after every close
Pullback inside a longer uptrend
The stock sits between its 20 and 50 day averages. It is 6% above its 200 day average, so the longer trend is still up. Momentum is neutral (RSI 47). The nearest support is the 20 day average at $50.80, and the nearest resistance the Pivot R1 at $52.10.
Short trendBearish
Long trendBullish
MomentumNeutral
StretchNormal
VolatilityHigh, 4.8%/day
Key levels
$68.7352 week high+34.5%
$57.86100 day average+13.2%
$55.3250 day average+8.3%
$52.52Swing high (Nov 12)+2.8%
$52.10Pivot R1+2.0%
$51.10Last close
$50.8020 day average−0.6%
$50.18Pivot−1.8%
$49.46Swing low (Oct 16)−3.2%
$49.17Pivot S1−3.8%
$47.87200 day average−6.3%
$22.5952 week low−55.8%
Indicators
RSI (14)
46.63
Middle of its range
Neutral
MACD
-1.02
Above its signal line
Bullish
Stochastic
67.1
Middle of its range
Neutral
ADX (14)
15.7
No clear trend
Williams %R
-25.7
Oversold below −80, overbought above −20
Neutral
CCI (20)
-46.2
Oversold below −100, overbought above 100
Neutral
Rate of change
+3.4%
Change over 10 sessions
Bullish
ATR (14)
$2.44
Typical daily range, 4.8% of price
MA 10Above
MA 20Above
MA 50Below
MA 100Below
MA 200Above
Moving sideways
Short trendNeutral
Long trendNot enough history
MomentumFading
StretchNormal
VolatilityNormal, 10.0%/day
Key levels
$68.7352 week high+34.5%
$57.86100 day average+13.2%
$55.3250 day average+8.3%
$52.52Swing high (Nov 12)+2.8%
$52.10Pivot R1+2.0%
$51.10Last close
$50.8020 day average−0.6%
$50.18Pivot−1.8%
$49.46Swing low (Oct 16)−3.2%
$49.17Pivot S1−3.8%
$47.87200 day average−6.3%
$22.5952 week low−55.8%
Indicators
RSI (14)
47.56
Middle of its range
Neutral
MACD
0.94
Below its signal line
Bearish
Stochastic
23.8
Middle of its range
Neutral
ADX (14)
33.8
Trending down
Williams %R
-73.5
Oversold below −80, overbought above −20
Neutral
CCI (20)
-101.2
Oversold below −100, overbought above 100
Oversold
Rate of change
−22.8%
Change over 10 sessions
Bearish
ATR (14)
$5.12
Typical daily range, 10.0% of price
MA 10Below
MA 20Below
MA 50Above
MA 100Above
MA 200–
What happened before, for TVTX
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how TVTX did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.
November seasonalityHow TVTX usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
Seasonality
How TVTX has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2012.
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
AI Auto Pilots
Paper trading
StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether TVTX is in one of them and how their past TVTX trades turned out.
Travere Therapeutics is a biopharmaceutical company based in San Diego, California. It develops and sells treatments for people with rare kidney and metabolic diseases. Its approved product, FILSPARI, is indicated to slow kidney function decline in adults with a rare kidney disease called primary IgAN. The company is also seeking approval of FILSPARI for another kidney condition, FSGS, and is developing pegtibatinase for HCU, a genetic metabolic disorder.